CY1107417T1 - Νεοι σταθεροι κρυσταλλοι υποκατεστημενου παραγωγου φαινυλοπροπιονικου οξεος και μεθοδος δια την παραγωγη αυτου - Google Patents

Νεοι σταθεροι κρυσταλλοι υποκατεστημενου παραγωγου φαινυλοπροπιονικου οξεος και μεθοδος δια την παραγωγη αυτου

Info

Publication number
CY1107417T1
CY1107417T1 CY20081100446T CY081100446T CY1107417T1 CY 1107417 T1 CY1107417 T1 CY 1107417T1 CY 20081100446 T CY20081100446 T CY 20081100446T CY 081100446 T CY081100446 T CY 081100446T CY 1107417 T1 CY1107417 T1 CY 1107417T1
Authority
CY
Cyprus
Prior art keywords
phynylpropynic
substituted
producing
acid production
new stable
Prior art date
Application number
CY20081100446T
Other languages
English (en)
Inventor
Kazuo Orita
Tomomi Koike
Original Assignee
Kyorin Pharmaceutical Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co., Ltd filed Critical Kyorin Pharmaceutical Co., Ltd
Publication of CY1107417T1 publication Critical patent/CY1107417T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Παρασκευή (S)- 2- [[3- [Ν- [4-[(4- φθοριοφαινόξυ) μεθύλ] καρβαμοϋλ]- 4- μεθοξυφαινύλ] μεθύλ] βουτανοϊκού οξέος (αναφέρεται επίσης και ως ένωση (ι)) σε βιομηχανική κλίμακα βασίζεται στην ανεύρεση κρυστάλλων ομοιογενών και εξαιρετικής σταθερότητος και εις την διαμόρφωση μιας παρασκευαστικής μεθόδου δια αυτήν. Νέοι κρύσταλλοι της ενώσεως (I) ομοιογενείς και εξαιρετικής σταθερότητος χαρακτηριζόμενοι από παρουσίαση γωνιών περιθλάσεως (2θ) εις τουλάχιστον 17.7°, 19.0° και 24.1° εις την περίθλαση πούδρας με ακτίνες - Χ παρασκευάζονται δια ανακρυσταλλώσεως από έναν αλκοολικό διαλύτη και δια καθαρισμού δια οξίνης βασικής κατεργασίας.
CY20081100446T 2001-12-11 2008-04-21 Νεοι σταθεροι κρυσταλλοι υποκατεστημενου παραγωγου φαινυλοπροπιονικου οξεος και μεθοδος δια την παραγωγη αυτου CY1107417T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001377077 2001-12-11
EP02783815A EP1462439B1 (en) 2001-12-11 2002-12-10 Novel stable crystals of substituted phenylpropionic acid derivative and process for producing the same

Publications (1)

Publication Number Publication Date
CY1107417T1 true CY1107417T1 (el) 2012-12-19

Family

ID=19185129

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100446T CY1107417T1 (el) 2001-12-11 2008-04-21 Νεοι σταθεροι κρυσταλλοι υποκατεστημενου παραγωγου φαινυλοπροπιονικου οξεος και μεθοδος δια την παραγωγη αυτου

Country Status (14)

Country Link
US (1) US7279596B2 (el)
EP (1) EP1462439B1 (el)
JP (1) JP4424728B2 (el)
KR (1) KR100876849B1 (el)
CN (1) CN1312121C (el)
AT (1) ATE390406T1 (el)
AU (1) AU2002349538B2 (el)
CA (1) CA2469882C (el)
CY (1) CY1107417T1 (el)
DE (1) DE60225841T2 (el)
DK (1) DK1462439T3 (el)
ES (1) ES2302857T3 (el)
PT (1) PT1462439E (el)
WO (1) WO2003050077A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006016637A1 (ja) * 2004-08-11 2008-05-01 杏林製薬株式会社 新規環状アミノ安息香酸誘導体
JP2007001912A (ja) * 2005-06-22 2007-01-11 Univ Of Tokyo 置換フェニルプロピオン酸誘導体
CN103951583B (zh) * 2006-12-06 2016-01-06 科内图斯医药公司 一种抑制剂的结晶形式

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4618845B2 (ja) 1999-06-09 2011-01-26 杏林製薬株式会社 ヒトペルオキシゾーム増殖薬活性化受容体（ＰＰＡＲ）αアゴニストとしての置換フェニルプロピオン酸誘導体
KR100683435B1 (ko) 1999-09-17 2007-02-20 교린 세이야꾸 가부시키 가이샤 ｏ-아니스아미드 유도체
TWI262185B (en) * 1999-10-01 2006-09-21 Eisai Co Ltd Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives

Also Published As

Publication number Publication date
EP1462439A1 (en) 2004-09-29
KR100876849B1 (ko) 2008-12-31
US20050228050A1 (en) 2005-10-13
JP4424728B2 (ja) 2010-03-03
DE60225841T2 (de) 2009-05-14
AU2002349538A1 (en) 2003-06-23
EP1462439B1 (en) 2008-03-26
CN1602295A (zh) 2005-03-30
ATE390406T1 (de) 2008-04-15
EP1462439A4 (en) 2006-02-01
CA2469882A1 (en) 2003-06-19
DE60225841D1 (de) 2008-05-08
WO2003050077A1 (fr) 2003-06-19
KR20040075000A (ko) 2004-08-26
ES2302857T3 (es) 2008-08-01
PT1462439E (pt) 2008-04-10
CN1312121C (zh) 2007-04-25
JPWO2003050077A1 (ja) 2005-04-21
US7279596B2 (en) 2007-10-09
DK1462439T3 (da) 2008-04-21
CA2469882C (en) 2009-09-29
AU2002349538B2 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
CY1105826T1 (el) Μεθοδος συνθεσης του (1s)-4,5-διμεθοξυ-1-(μεθυλαμινομεθυλ)βενζοκυκλοβουτανιου και των αλατων προσθηκης αυτου και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης αυτης με φαρμακευτικως αποδεκτο οξυ
EE05284B1 (et) 2-arlpropioonhappe amiidide R-enantiomeerid, nende valmistamismeetod, farmatseutiline kompositsioon ja 2-arlpropioonhapete R-enantiomeerid
HUP0301661A2 (hu) Bifenil-karboxamidok, intermedierjeik, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó mikrobicid készítmények
CY1113873T1 (el) Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90
CA2493794A1 (en) Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
CY1107417T1 (el) Νεοι σταθεροι κρυσταλλοι υποκατεστημενου παραγωγου φαινυλοπροπιονικου οξεος και μεθοδος δια την παραγωγη αυτου
NO20082747L (no) Arylisoksazol-4-yl-imidazolderivater
EA200701687A1 (ru) Гидрохлорид аморфного лерканидипина
UY27548A1 (es) Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas
EA200400140A1 (ru) Пероральные противодиабетические агенты
CY1106677T1 (el) Παρασκευη ν1-(2’-πυριδυλ)-1, 2-προπανοδιαμινο σουλφαμικου οξεος και χρηση αυτου στη συνθεση βιολογικως δραστικων πιπεραζινων
BR0311984A (pt) Difenilazetidinonas substituìdas cationicamente, processo para a sua preparação, medicamentos contendo estes compostos e sua aplicação
TW200722415A (en) New process
NO20054225L (no) Benzamid-derivater som oksytocin-agonister og vasopressin-antagonister
BRPI0520433A2 (pt) sais farmaceuticamente aceitáveis de 2,4,6-trimetil-3-hidroxipiridina, com ácidos dicarboxìlicos inferiores e método para preparação dos mesmos
PT1225174E (pt) Cristais de mirtazapina anidros e processo para a sua producao
NO20082005L (no) Syntese av renininhibitorer omfattende en cyklotilfoyelsesreaksjon
EA200201055A1 (ru) Новый стабильный кристалл производного тиазолидиндиона и способ его получения
Yan et al. Synthesis and study on insecticidal activity of new heterocyclic chalcone derivatives
RU2008100036A (ru) Кристаллические формы производного пирролотриазина
ITRM20010729A1 (it) Sale di acetil l-carnitina con un acido organico dicarbossilico e procedimento per la sua preparazione.
DK0947499T3 (da) Fremgangsmåde til fremstilling af racemisk sertralin
Sargsyan et al. Synthesis of ethyl 5-acetyl-1-R-4-aryl-6-hydroxy-6-methyl-2-oxopiperidine-3-carboxylates
Tarikogullari et al. Synthesis and anticonvulsant activity of some alkanamide derivatives
BRPI0408148A (pt) derivados de ácido benzoilureidopiridil-piperidina e -pirrolidina-carboxìlico, processos para a preparação e uso dos mesmos